|Country||United States - SIR Ranking of United States||
|Subject Area and Category||Immunology and Microbiology|
Immunology and Allergy
|Scope||Tumor immunology deals with the natural or therapy-induced recognition of cancers, as well as with the intricate interplay between oncogenesis, inflammation and immunosurveillance. This high-profile journal, OncoImmunology specifically deals with tumor immunology. Recent progress has allowed for the first clinical demonstration (and FDA approval) of anticancer immunotherapies. There is also an ever-growing suspicion that - unexpectedly - many of the currently used chemotherapeutic agents depend in their efficacy on the active contribution of immune effectors. To use a drastic metaphor, oncologists who applied successful chemotherapeutic (or radiotherapeutic) regimens have taken advantage of the immune system's capacity to recognize tumor-specific or tumor-associated antigens and to control cancer (stem) cell growth, without being aware of the invisible helping hands. As a result, immunological biomarkers are becoming ever more important to determine the prognosis of cancers and to predict the efficacy of chemotherapies. There is also a strong rationale in favor of combining conventional anticancer therapies with immunotherapies. OncoImmunology accepts high-profile submissions in the fundamental, translational and clinical areas of tumor immunology. Submissions dealing with solid or hematological cancers, inflammation, innate and acquired immune responses are welcome. OncoImmunology publishes Original Research Articles, Brief Reports, Reviews, Commentaries and Meeting Reports in these area of research.|
|Join the conversation about this journal|
The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.
|Immunology and Allergy||2013||Q2|
|Immunology and Allergy||2014||Q2|
|Immunology and Allergy||2015||Q1|
|Immunology and Allergy||2016||Q1|
|Immunology and Allergy||2017||Q1|
|Immunology and Allergy||2018||Q1|
The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.
This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.
|Cites per document||Year||Value|
|Cites / Doc. (4 years)||2012||0.000|
|Cites / Doc. (4 years)||2013||4.757|
|Cites / Doc. (4 years)||2014||3.942|
|Cites / Doc. (4 years)||2015||3.814|
|Cites / Doc. (4 years)||2016||3.654|
|Cites / Doc. (4 years)||2017||3.786|
|Cites / Doc. (4 years)||2018||4.469|
|Cites / Doc. (3 years)||2012||0.000|
|Cites / Doc. (3 years)||2013||4.757|
|Cites / Doc. (3 years)||2014||3.942|
|Cites / Doc. (3 years)||2015||3.814|
|Cites / Doc. (3 years)||2016||3.558|
|Cites / Doc. (3 years)||2017||4.182|
|Cites / Doc. (3 years)||2018||4.683|
|Cites / Doc. (2 years)||2012||0.000|
|Cites / Doc. (2 years)||2013||4.757|
|Cites / Doc. (2 years)||2014||3.942|
|Cites / Doc. (2 years)||2015||3.595|
|Cites / Doc. (2 years)||2016||3.778|
|Cites / Doc. (2 years)||2017||4.218|
|Cites / Doc. (2 years)||2018||4.909|
Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years.
Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal.
Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total number of citations received by the journal’s documents.
|External Cites per document||2012||0|
|External Cites per document||2013||2.968|
|External Cites per document||2014||3.053|
|External Cites per document||2015||3.317|
|External Cites per document||2016||3.009|
|External Cites per document||2017||3.646|
|External Cites per document||2018||4.331|
|Cites per document||2012||0.000|
|Cites per document||2013||4.757|
|Cites per document||2014||3.942|
|Cites per document||2015||3.814|
|Cites per document||2016||3.558|
|Cites per document||2017||4.182|
|Cites per document||2018||4.683|
International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address.
Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers.
Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.